VASCULAR DISEASES
Angiosarcoma of the face and scalp
Cancer 59:1046–1057, 1987
Congenital lymphedema
Eosinophilic vasculitis syndrome
Semin Dermatol 14:106–110,
1995
Giant cell arteritis
Rev Rheum Engl Ed 63:145–147, 1996
Hemangioma – diffuse hemangioma
AD 139:869–875, 2003
Henoch–Schönlein purpura – scalp and facial edema
Ped Derm
9:311, 1992
Idiopathic bilateral external jugular vein thrombosis
Angiology
52:69–71, 2001
Lymphatic malformation
Superior vena cava syndrome
Clin Exp Derm 25:198–200, 2000
Vascular malformation
EDEMA, LEGS
AUTOIMMUNE DISEASES, AND DISEASES
OF IMMUNE DYSFUNCTION
Allergic contact dermatitis – complicating venous stasis
Rook
p.2261, 1998, Sixth Edition
Angioedema
Am J Med 113:580–586, 2002
Lupus erythematosus, systemic – pitting edema of legs
Rheumatol
Int 18:159–160, 1999; Br J Rheumatol 37:104–105, 1998
Morphea – linear morphea
Clin Exp Dermatol 24:467–468,
1999; JAAD 38:366–368, 1998; BJD 134:594–595, 1996;
generalized morphea – non-pitting edema of trunk and
extremities
Rook p.2511, 1998, Sixth Edition
Polymyalgia rheumatica – distal extremity swelling, pitting
edema
Arthritis Rheum 39:73–80, 1996
Serum sickness
Am J Med 113:580–586, 2002
Urticaria
Am J Med 113:580–586, 2002
DEGENERATIVE DISEASES
Paralysis of any cause
DRUG REACTIONS
Acyclovir therapy – peripheral edema
JAAD 18:1142–1143, 1988
Antidepressants
Am J Med 113:580–586, 2002
Anti-hypertensives
Am J Med 113:580–586, 2002; Rook p.2247,
1998, Sixth Edition
Beta blockers
Am J Med 113:580–586, 2002; Rook p.2247,
1998, Sixth Edition
Calcium channel blockers
Am J Med 113:580–586, 2002
Clofazimine – pedal edema
Int J Lepr Other Mycobact Dis
61:636, 1993
Clonidine
Am J Med 113:580–586, 2002
Corticosteroids
Am J Med 113:580–586, 2002
Diazoxide
Am J Med 113:580–586, 2002
GCSF – recombinant human GCSF; livedo reticularis, edema, with
thrombotic and necrotizing panniculitis
BJD 142:834–836, 2000
Gemcitabine – edema of legs with subsequent sclerodermoid
changes
JAAD 51:S73–76, 2004
Gene transfer of naked DNA encoding vascular endothelial
growth factor
Ann Intern Med 132:880–884, 2000
Guanethidine
Am J Med 113:580–586, 2002
Hormones (estrogens, progesterones)
Am J Med 113:580–586,
2002
Hydralazine
Am J Med 113:580–586, 2002
Insulin edema – generalized, 1–3 days after ketoacidosis
South Med J 2:445, 1979
Interleukin-2
Am J Med 113:580–586, 2002
Methyldopa
Am J Med 113:580–586, 2002
Methysergide – retroperitoneal fibrosis
Ghatan p.252, 2002,
Second Edition
Minoxidil
Am J Med 113:580–586, 2002
Monoamine oxidase inhibitor anti-depressants
Am J Med
113:580–586, 2002; Rook p.2247, 1998, Sixth Edition
Nifedipine (calcium channel blockers)
Rook p.2247, 1998,
Sixth Edition
Non-selective cyclo-oxygenase inhibitors
Am J Med
113:580–586, 2002
Non-steroidal anti-inflammatory agents
Am J Med
113:580–586, 2002
Phenylbutazone
Am J Med 113:580–586, 2002
Pioglitazone
Am J Med 113:580–586, 2002
Pramipexole – peripheral edema
Arch Neurol 57:729–732, 2000
Reserpine
Am J Med 113:580–586, 2002
Rosiglitazone
Am J Med 113:580–586, 2002
Selective cyclo-oxygenase-2 inhibitors
Am J Med 113:580–586,
2002
Testosterone
Am J Med 113:580–586, 2002
Troglitazone
Am J Med 113:580–586, 2002
Do'stlaringiz bilan baham: